Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Cancer Research
|
January 16, 2026
Overcoming the Limits of Inhibition: Mutant-Selective BRAF Degraders
Pan-Yu Chen, Gideon Bollag
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology
|
June 16, 2020
[Effects of shrub patch pattern on runoff and sediment yield]
Ming Zhao, Xiao-Nan Yang, Pan-Yu Chen, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2026
BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial
Michael S Gordon, Richard D Carvajal, Alexander Spira, et al.
Molecular Cell
|
November 18, 2009
Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling
Sheng Gao, Claudio Alarcón, Gopal Sapkota, et al.
Archives of Gynecology and Obstetrics
|
March 11, 2019
Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: an analysis of 1188 cycles
Ying-Chun Guo, Pan-Yu Chen, Ting-Ting Li, et al.
Nature Communications
|
October 25, 2017
Survival of pancreatic cancer cells lacking KRAS function
Mandar Deepak Muzumdar, Pan-Yu Chen, Kimberly Judith Dorans, et al.
JCI Insight
|
September 8, 2023
Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation
Pan-Yu Chen, Benjamin J Huang, Max Harris, et al.
Cancer Research
|
December 28, 2017
Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
Pan-Yu Chen, Mandar Deepak Muzumdar, Kimberly Judith Dorans, et al.
World Journal of Gastroenterology
|
November 10, 2021
Standard liver weight model in adult deceased donors with fatty liver: A prospective cohort study
Bo Li, Pan-Yu Chen, Yi-Fei Tan, et al.
Nature Communications
|
November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models
Connor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Cancer Research
|
January 16, 2026
Overcoming the Limits of Inhibition: Mutant-Selective BRAF Degraders
Pan-Yu Chen, Gideon Bollag
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology
|
June 16, 2020
[Effects of shrub patch pattern on runoff and sediment yield]
Ming Zhao, Xiao-Nan Yang, Pan-Yu Chen, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2026
BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial
Michael S Gordon, Richard D Carvajal, Alexander Spira, et al.
Molecular Cell
|
November 18, 2009
Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling
Sheng Gao, Claudio Alarcón, Gopal Sapkota, et al.
Archives of Gynecology and Obstetrics
|
March 11, 2019
Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: an analysis of 1188 cycles
Ying-Chun Guo, Pan-Yu Chen, Ting-Ting Li, et al.
Nature Communications
|
October 25, 2017
Survival of pancreatic cancer cells lacking KRAS function
Mandar Deepak Muzumdar, Pan-Yu Chen, Kimberly Judith Dorans, et al.
JCI Insight
|
September 8, 2023
Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation
Pan-Yu Chen, Benjamin J Huang, Max Harris, et al.
Cancer Research
|
December 28, 2017
Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
Pan-Yu Chen, Mandar Deepak Muzumdar, Kimberly Judith Dorans, et al.
World Journal of Gastroenterology
|
November 10, 2021
Standard liver weight model in adult deceased donors with fatty liver: A prospective cohort study
Bo Li, Pan-Yu Chen, Yi-Fei Tan, et al.
Nature Communications
|
November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models
Connor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Page
of 2